Home

Our Technology

Our platform technology unlocks the robust immuno-resolving properties of endogenous bioactive lipids to create novel, non-immunosuppressive therapies for treatment of Inflammatory Bowel Disease (IBD).

Proven Lipid Biology

Leveraging the robust immuno-resolving properties of endogenous bioactive lipids

HEALER™ Platform

Chemically transforming endogenous bioactive lipids into small molecules with superior pharmaceutical properties

Intellectual Property

Long-term composition of matter patent protection on new molecular entities via the HEALER platform

"We are committed to creating innovative products that improve the lives of patients suffering from IBD."